Stockscreener 앱 받기
112.14
0.14%
0.16
시간 외 거래:
111.50
-0.64
-0.57%
Guardant Health Inc 주식(GH)의 최신 뉴스
Guardant Health: Shield Colorectal Cancer Screening To Sustain Growth - Seeking Alpha
Guardant Health stock hits 52-week high at 113.98 USD By Investing.com - Investing.com Nigeria
IPO Launch: How does Guardant Health Inc compare to its peersJuly 2025 Reactions & Daily Profit Maximizing Tips - baoquankhu1.vn
Guardant Health stock hits 52-week high at 113.98 USD - Investing.com India
Sumitomo Mitsui Trust Group Inc. Has $47.12 Million Position in Guardant Health, Inc. $GH - MarketBeat
Global Pan-Genomic and Multi-Gene Panel Testing Market Forecast to Hit US$ 25.91 Billion by 2032 at 12.04% CAGR, Driven by Growing Demand for Comprehensive Multi-Gene Diagnostics: AnalystView Market Insights - GlobeNewswire Inc.
BLOODPAC Publishes New Standards for Liquid Biopsy Tests That Monitor for Cancer Recurrence - PA Media
Guardant Health (NASDAQ:GH): Strongest Q3 Results from the Testing & Diagnostics Services Group - Yahoo Finance
Guardant Health Announces Strong 2025 Preliminary Revenue Growth - The Globe and Mail
Guardant Health guides Q4 and FY25 revenue above consensus - MSN
Guardant Health (NASDAQ:GH) Reaches New 12-Month HighStill a Buy? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), SI-Bone (SIBN) and Guardant Health (GH) - The Globe and Mail
Guardant Health shares up 2.4% after preliminary Q4 revenue beats estimates - marketscreener.com
Guardant Health, Inc. (GH) Stock Analysis: Strong Buy Potential with 38.5% Revenue Growth and Robust Analyst Support - DirectorsTalk Interviews
Guardant Health rises after Q4 revenue surpasses estimate - TradingView — Track All Markets
Guardant Health, Inc. $GH Shares Sold by D.A. Davidson & CO. - MarketBeat
Guardant Health Sees 39% Rise in Q4 Preliminary Revenue - marketscreener.com
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results - BioSpace
Guardant Health (GH) Surpasses Revenue Estimates with Strong Onc - GuruFocus
Guardant Health prelim Q4 revenue rises 39%, beats expectations - TradingView — Track All Markets
Guardant Health Q4 total revenue of approx $280 million - marketscreener.com
Discipline and Rules-Based Execution in GH Response - Stock Traders Daily
Guggenheim Analyst is Bullish on Guardant Health, Inc. (GH) - Finviz
How Recent Analyst Targets Are Shaping The Evolving Story For Guardant Health (GH) - Yahoo Finance
Guardant Health (GH) Is Up 8.3% After TRICARE Adds No-Copay Shield Coverage For Service Members - Yahoo Finance
Is Guardant Health (GH) Share Surge Justified By Recent Valuation Signals? - Yahoo Finance
Guardant Health is the top performing healthcare services stock YTD - MSN
Guardant Health’s Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families in Florida - Florida Hospital News and Healthcare Report
Stifel raises Guardant Health stock price target to $120 on growth outlook - Investing.com Canada
Guardant Health (GH): Stifel Raises Price Target to $120.00 | GH Stock News - GuruFocus
Insider Sell: Terilyn Monroe Sells Shares of Guardant Health Inc (GH) - GuruFocus
Insider Selling: Guardant Health (NASDAQ:GH) Insider Sells 10,031 Shares of Stock - MarketBeat
Clinical Labs Hope to Head Off Looming Medicare Cuts - Barron's
Aug Swings: How strong is Guardant Health Inc. stock balance sheetJuly 2025 Market Mood & Technical Buy Zone Confirmation - ulpravda.ru
How Guardant Health Inc. stock compares to industry benchmarks2025 EndofYear Setup & Expert Curated Trade Setups - ulpravda.ru
Can Guardant Health Inc. stock continue upward trendWeekly Investment Summary & Reliable Breakout Forecasts - ulpravda.ru
Guardant Health’s Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families - The Joplin Globe
Will Guardant Health Inc. stock deliver better than expected guidanceTrendline Breakouts & Rapid Wealth Accumulation - ulpravda.ru
Guardant Health, Inc.Common Stock (NQ: GH - FinancialContent
Assessing Guardant Health (GH) Valuation After Analyst Upgrades And New Cancer Test Partnerships - Yahoo Finance
Guardant Health stock hits 52-week high at 112.43 USD By Investing.com - Investing.com Nigeria
Guardant Health (NASDAQ:GH) Sets New 1-Year HighHere's Why - MarketBeat
Guardant Health stock hits 52-week high at 112.43 USD - Investing.com
Guardant Health stock jumps 7% as Evercore downgrades — what investors watch next - TechStock²
GH Virtual Meeting Scheduled by BTIG for January 12 - GuruFocus
Guardant Health (NASDAQ:GH) Stock Rating Lowered by Evercore ISI - MarketBeat
Evercore ISI Group downgrades Guardant Health (GH) - MSN
GH: Evercore ISI Group Downgrades Guardant Health While Raising Price Target | GH Stock News - GuruFocus
GH: Guggenheim Raises Price Target for Guardant Health to $115 | - GuruFocus
VIRGINIA RETIREMENT SYSTEMS ET Al Takes Position in Guardant Health, Inc. $GH - MarketBeat
Allspring Global Investments Holdings LLC Makes New $39.52 Million Investment in Guardant Health, Inc. $GH - MarketBeat
What analysts say about Guardant Health Inc stockBear Market Strategies & Explosive Growth Opportunities - earlytimes.in
Calamos Advisors LLC Takes $2.78 Million Position in Guardant Health, Inc. $GH - MarketBeat
Canaccord Names Guardant Health (GH) Top Life Science Pick, Cites Strong Growth and Low Downside - Finviz
2.51%
0.74%
자본화:
|
볼륨(24시간):